Validating RNAseq-signatures of vorinostat (VOR) sensitivity and resistance in patients with newly diagnosed glioblastoma (GBM) treated with VOR, temozolomide and radiation therapy in Alliance N0874/ABTC-0902

Manmeet Ahluwalia

Validating RNAseq-signatures of vorinostat (VOR) sensitivity and resistance in patients with newly diagnosed glioblastoma (GBM) treated with VOR, temozolomide and radiation therapy in Alliance N0874/ABTC-0902

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Jun 2016
Event	ASCO Annual Meeting - Chicago, IL Duration: Jun 1 2016 → …

Conference

Conference	ASCO Annual Meeting
Period	6/1/16 → …

Disciplines

Medicine and Health Sciences

Cite this

@conference{a73cd0fae3b04ca88319a186a1de8150,

title = "Validating RNAseq-signatures of vorinostat (VOR) sensitivity and resistance in patients with newly diagnosed glioblastoma (GBM) treated with VOR, temozolomide and radiation therapy in Alliance N0874/ABTC-0902",

author = "Manmeet Ahluwalia",

year = "2016",

month = jun,

language = "American English",

note = "ASCO Annual Meeting ; Conference date: 01-06-2016",

}